Építés alatt – nem éles oldal
Belépés
Befejeződött1. fázis

Bioequivalence study of a proposed biosimilar insulin glargine U300 with Toujeo®

Key facts

Where
Neuss, NémetországSee the site
Phase
1. fázis

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Forrás: 2023-504509-36-00: ki vehet részt

Where in Németország

  • PROFIL Institut fuer Stoffwechselforschung GmbHNeuss, NémetországNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Biocon Sdn. Bhd.
Trial code
EU 2023-504509-36-00
Record updated
2023. június 20.